Description

Tafluprost is a synthetic prostaglandin F2α analog and a potent, selective FP prostanoid receptor agonist. It is a high-purity active pharmaceutical ingredient (API) of significant importance in the development and manufacturing of advanced ophthalmic solutions. This compound is primarily required by pharmaceutical companies and research institutions focused on creating treatments for ocular conditions such as glaucoma and ocular hypertension, where it effectively reduces intraocular pressure.

Application

• Primary Active Pharmaceutical Ingredient (API) in prescription ophthalmic solutions for glaucoma.
• Key Component in novel drug delivery systems, including preservative-free eye drops.
• Research Chemical for pharmacological studies on prostaglandin receptors and ocular pharmacology.
• Reference Standard for quality control and analytical method development in pharmaceutical laboratories.
• Intermediate in the synthesis of related prostaglandin analogs for therapeutic use.
• Formulation Development for combination therapies targeting elevated intraocular pressure.

Basic Information

Product Name	Tafluprost
CAS No.	209860-87-7
Molecular Formula	C₂₅H₃₄F₂O₅
Molecular Weight	452.53 g/mol
Synonyms	Tafluprost; AFP-168; Bimatoprost Impurity F; (5Z)-7-{(1R,2R,3R,5S)-2-[(1E)-3,3-Difluoro-4-phenoxy-1-buten-1-yl]-3,5-dihydroxycyclopentyl}-5-heptenoic Acid Isopropyl Ester; AFP 168; 9-KetofLUOROPROST; Prostaglandin F2α analog AFP-168; Tafluprostum
EINECS	Contact for details

Quality Control

Our Tafluprost is manufactured under strict quality management systems, targeting specifications suitable for pharmaceutical development. Each batch is subjected to comprehensive analytical testing, including identity confirmation, purity assay, and control of specified impurities to ensure consistency and reliability. Certificates of Analysis (COA) compliant with current industry standards are provided with every shipment.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at controlled room temperature (15-25°C). The product is hygroscopic (moisture-sensitive) and must be kept under inert conditions or in a desiccated environment after opening to maintain stability and potency.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to reference spectrum
Identification (HPLC)	Retention time corresponds to reference standard
Assay (HPLC)	≥ 98.5%
Related Substances (HPLC)	Total impurities ≤ 1.0% Any single unknown impurity ≤ 0.2%
Residual Solvents (GC)	Complies with ICH Q3C guidelines
Water Content (KF)	≤ 0.5%
Specific Rotation	Contact for details

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.